MetLife delivers big profits, but growth jitters rattle analysts and investors

MetLife's first-quarter 2026 earnings showcased a robust 30% rise in net income available to common shareholders, reaching $1.1 billion, fueled by a 5% increase in premiums, fees, and other revenues to $14.3 billion. This strong performance was not solely reliant on investment income but reflected broad-based gains across multiple business segments, underscoring a healthier and more diversified earnings pattern.

Asia emerged as a pivotal growth engine for MetLife, contributing $487 million in adjusted earnings during Q1, highlighting the region’s vigorous insurance demand despite global macroeconomic volatility. This surge in Asia’s profitability, combined with a 58% jump in variable investment income to $518 million and a 10% rise in premiums and fees excluding pension risk transfers, exemplifies MetLife’s successful strategy of pairing volume growth with favorable underwriting conditions across its portfolio.

MetLife's growth trajectory has raised red flags among analysts, as its net premiums earned have expanded at a modest 2.7% annualized rate over the past five years, trailing the broader insurance industry and signaling soft demand relative to peers. This sluggish premium growth is compounded by a similarly tepid 3% annual increase in book value per share over the last two years, reflecting limited asset expansion and raising concerns about the company's underlying financial health.

Wall Street's outlook for MetLife remains cautious, with sell-side analysts forecasting a stall in revenue growth over the next 12 months—a notable deceleration from the prior 4.8% annualized pace—suggesting constrained upside potential. This skepticism is echoed in the company’s earnings performance, where EPS growth has underperformed sector averages, and book value per share has even declined by 10.8% annually over five years, intensifying doubts about sustainable growth.

Despite these growth headwinds, MetLife’s stock trades at a relatively elevated valuation, with forward price-to-book ratios hovering around 1.9x to 2x and share prices in the mid-$80s. This premium valuation implies that investors are pricing in significant optimism, which may be at odds with the company’s modest growth metrics and stagnant financial fundamentals, thereby raising questions about the stock’s risk-reward balance in the current market environment.

MetLife’s strategic diversification into retirement solutions and employer benefits is a deliberate pivot designed to stabilize and grow earnings beyond the traditional insurance model. By early 2026, Group Benefits had surged with adjusted earnings of $439 million in Q1, a 19% year-over-year increase fueled by a 15% rise in sales of core and voluntary products, underscoring its role as a reliable revenue pillar. This focus aligns with the company’s New Frontier strategy, which explicitly aims to extend leadership in Group Benefits and accelerate growth in retirement platforms, reflecting a clear shift toward less interest-rate-sensitive and more recurring revenue streams.

The Retirement and Income Solutions (RIS) segment emerges as a critical growth engine that enhances MetLife’s earnings durability by reducing dependence on volatile capital markets. In Q1 2026, RIS adjusted earnings climbed 11% to $451 million, while adjusted premiums, fees, and other revenues—excluding pension risk transfers—soared 58% to $1.5 billion. This robust growth was driven by expanding offerings such as U.K. longevity reinsurance, post-retirement benefits, and structured settlements, illustrating how MetLife leverages innovative liability-transfer products to deepen its foothold in institutional retirement markets.